Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice (Q46911481)

From Wikidata

Revision as of 18:42, 19 July 2024 by Twofivesixbot (talk | contribs) (‎Updated Item: rm P2888 pointing to scigraph.springernature.com; site discontinued and merely duplicating DOI)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on 7 November 2007

Language	Label	Description	Also known as
English	Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice	scientific article published on 7 November 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Michele T. Yip-Schneider

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

author name string

Sabrina C Wentz

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

Huangbing Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

Matthew Hennig

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

Patrick J Klein

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

Judith Sebolt-Leopold

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

C Max Schmidt

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

publication date

7 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Gastrointestinal Surgery

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

12

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

30-37

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver

1 reference

https://api.crossref.org/works/10.1007%2FS11605-007-0396-4

21 January 2018

Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of rat hepatocarcinogenesis by acyclic retinoid is accompanied by reduction in emergence of both TGF-alpha-expressing oval-like cells and activated hepatic stellate cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prometheus' challenge: molecular, cellular and systemic aspects of liver regeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased MAPK expression and activity in primary human hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary liver cancer: worldwide incidence and trends

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRAF mutation predicts sensitivity to MEK inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of liver tumors in transforming growth factor alpha transgenic mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A morphologic classification of proliferative and neoplastic hepatic lesions in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoprevention of hepatocellular carcinoma: use of tamoxifen in an animal model of hepatocarcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the mitogen-activated protein kinase cascade to treat cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor expression via activation of nuclear factor- B

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus infection: epidemiology and vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of hepatic preneoplasia for cancer chemoprevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of hepatic preneoplasia in risk identification and early detection of neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17987349

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11605-007-0396-4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/17987349

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46911481&oldid=2208241469"